Financials
- Fiscal year
- 2026
- Total assets
- €168,533
- Loss
- -€238,871
- Solvency
- -2115.0%
Turnover▼ 87.5%
Net result
20182021
ViroVet
InactiveOverview
Activity
Research and development on biotechnology
NACE 72101NACE 72110
Size
€168,533total assets 2026
- Equity
- -€3.6m
- Loss
- -€238,871
Net result +84%: 6-month year
Financial health
Inactive: no score
Structure
- Board
- 1 member
Auditor: Pwc BedrijfsrevisorenAccounts 209 d early
Signals- Negative equityLatest accounts filed on timeShow the evidence
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2026 annual accounts show negative equity and a net loss.
NBB · annual accounts 2026Equity per financial year
181920212223242526
2018 to 2026 · latest year -€3.6m
neutral · Latest accounts filed on time
The financial year that closed on 25-06-2026 was due by 25-01-2027 and was filed on 30-06-2026, 209 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
209 d early
2025
31 d early
2024
30 d early
2023
65 d early
2022
68 d early
2021
45 d early
2020
54 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 72 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (1)
- End & cessationResignations: CAPRICORN PARTNERS, BIOTECH FONDS…
- Annual accounts filedfiscal year 2026 · full…
- Annual accounts filedfiscal year 2025 · full…
Key points
By topic
Board & ownership
- Board
- 1 member
- Known shareholders
- 48.72%
- Auditor
- Pwc Bedrijfsrevisoren
Go to Board & ownership
Network & group
- Connected companies
- 19
Timeline
- Events
- 35
- Since
- 2015
- 27-08-2026End & cessation
- 30-06-2026Annual accounts filed
- 30-06-2026Annual accounts filed
Company details
- Legal form
- Public limited company
- Activity
- Research and development on biotechnologyNACE 72101
- Founded
- 06-08-2015
- Year ends
- 25-06
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 4
- Purpose
- Het onderzoek naar, de ontwikkeling van, de octrooiering van, de verkoop en…
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a date before the end?Company as of a date How is this company connected to another party?Network investigator How is the Research and development on biotechnology sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.